CME Group Inc (CME) Stake Decreased by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its holdings in CME Group Inc (NASDAQ:CME) by 3.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 421,352 shares of the financial services provider’s stock after selling 17,272 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 0.12% of CME Group worth $71,718,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. First Citizens Bank & Trust Co. increased its holdings in CME Group by 1.4% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 20,939 shares of the financial services provider’s stock worth $3,564,000 after purchasing an additional 295 shares during the period. Oak Ridge Investments LLC increased its holdings in CME Group by 6.2% during the 2nd quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock worth $860,000 after purchasing an additional 306 shares during the period. Girard Partners LTD. increased its holdings in CME Group by 10.3% during the 2nd quarter. Girard Partners LTD. now owns 3,492 shares of the financial services provider’s stock worth $572,000 after purchasing an additional 326 shares during the period. Trust Co. of Vermont increased its holdings in CME Group by 0.8% during the 2nd quarter. Trust Co. of Vermont now owns 43,772 shares of the financial services provider’s stock worth $7,175,000 after purchasing an additional 327 shares during the period. Finally, Front Row Advisors LLC increased its holdings in CME Group by 3.9% during the 2nd quarter. Front Row Advisors LLC now owns 8,882 shares of the financial services provider’s stock worth $1,506,000 after purchasing an additional 335 shares during the period. Hedge funds and other institutional investors own 84.29% of the company’s stock.

Shares of NASDAQ CME opened at $183.24 on Thursday. The company has a current ratio of 1.09, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. The firm has a market cap of $61.95 billion, a price-to-earnings ratio of 29.57, a P/E/G ratio of 3.44 and a beta of 0.64. CME Group Inc has a 12-month low of $135.61 and a 12-month high of $185.11.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.03. The business had revenue of $904.20 million for the quarter, compared to analysts’ expectations of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. As a group, equities research analysts expect that CME Group Inc will post 6.63 EPS for the current year.

Several research analysts have commented on the company. Compass Point assumed coverage on CME Group in a report on Monday, July 9th. They set a “neutral” rating and a $170.00 price objective on the stock. Wells Fargo & Co raised their price objective on CME Group from $175.00 to $177.00 and gave the stock a “market perform” rating in a report on Friday, October 26th. BidaskClub downgraded CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, July 10th. Deutsche Bank restated a “buy” rating and set a $192.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday, October 11th. Finally, Berenberg Bank set a $184.00 price objective on CME Group and gave the stock a “hold” rating in a report on Thursday, September 20th. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. CME Group presently has an average rating of “Buy” and a consensus price target of $181.54.

In other news, President Bryan T. Durkin sold 11,509 shares of the firm’s stock in a transaction on Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the completion of the sale, the president now owns 64,862 shares of the company’s stock, valued at approximately $10,508,292.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the completion of the sale, the director now directly owns 3,900 shares of the company’s stock, valued at approximately $636,363. The disclosure for this sale can be found here. Insiders have sold a total of 29,188 shares of company stock worth $4,973,607 in the last ninety days. Insiders own 0.43% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: Balance Sheet

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply